iBio IBIO
NASDAQ IBIO
$1.43 -0.04 (-2.72%)
At close: Aug 21, 2026 · 4:00 PM EDT

iBio (IBIO) Restructuring Costs (2018 - 2021)

iBio (IBIO) posted quarterly Restructuring Costs of $61000.0 for Q4 2021, down 65.54% year-over-year from $177000.0 in Q4 2020, and down 67.72% quarter-over-quarter from $189000.0 in Q3 2021.

iBio (IBIO) Restructuring Costs (2018 - 2021) Analysis & Trends

iBio (IBIO) has reported Restructuring Costs for 4 consecutive years, with $61000.0 the latest figure, recorded in Q4 2021.

  • In Q4 2021, Restructuring Costs fell 65.54% year-over-year to $61000.0; the TTM figure through Jun 2022 stood at $250000.0 (down 66.4% YoY), while the FY2022 annual figure was $250000.0, down 66.4% from the prior year.
  • Restructuring Costs retreated to $61000.0 in Q4 2021 per IBIO's latest filing, from $189000.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $304000.0 in Q4 2018 and bottomed at $61000.0 in Q4 2021.
  • Historically, Restructuring Costs has averaged $197214.3 across 4 years, with a median of $187000.0 in 2020.
  • Annual changes were most pronounced in 2020 — Restructuring Costs grew 8.19% — and 2021, when it slumped 65.54%.
  • iBio's Restructuring Costs stood at $304000.0 in 2018, then tumbled by 45.72% to $165000.0 in 2019, then increased by 7.27% to $177000.0 in 2020, then plunged by 65.54% to $61000.0 in 2021.
  • Business Quant data shows IBIO's Restructuring Costs at $61000.0 in Q4 2021, $189000.0 in Q3 2021, and $193000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 iBio 172.22 Mn 172.22 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 61,000.00
Sep 30, 2021 189,000.00
Jun 30, 2021 193,000.00
Mar 31, 2021 189,000.00
Dec 31, 2020 177,000.00
Sep 30, 2020 185,000.00
Jun 30, 2020 185,000.00
Mar 31, 2020 180,000.00
Dec 31, 2019 165,000.00
Sep 30, 2019 171,000.00
Jun 30, 2019 259,000.00
Mar 31, 2019 265,000.00
Dec 31, 2018 304,000.00
Sep 30, 2018 238,000.00